348 related articles for article (PubMed ID: 18236722)
41. Adverse event reporting and developments in radiation biology after normal tissue injury: International Atomic Energy Agency consultation.
Chen Y; Trotti A; Coleman CN; Machtay M; Mirimanoff RO; Hay J; O'brien PC; El-Gueddari B; Salvajoli JV; Jeremic B
Int J Radiat Oncol Biol Phys; 2006 Apr; 64(5):1442-51. PubMed ID: 16414207
[TBL] [Abstract][Full Text] [Related]
42. Amifostine is a potent radioprotector of salivary glands in radioiodine therapy. Structural and ultrastructural findings.
Kutta H; Kampen U; Sagowski C; Brenner W; Bohuslavizki KH; Paulsen F
Strahlenther Onkol; 2005 Apr; 181(4):237-45. PubMed ID: 15827693
[TBL] [Abstract][Full Text] [Related]
43. Medicine. Modulation of radiation injury.
Coleman CN; Stone HB; Moulder JE; Pellmar TC
Science; 2004 Apr; 304(5671):693-4. PubMed ID: 15118152
[No Abstract] [Full Text] [Related]
44. The preclinical basis for broad-spectrum selective cytoprotection of normal tissues from cytotoxic therapies by amifostine (Ethyol).
Capizzi RL
Eur J Cancer; 1996; 32A Suppl 4():S5-16. PubMed ID: 8976816
[TBL] [Abstract][Full Text] [Related]
45. Amifostine.
Rasey JS
Cancer Biother Radiopharm; 1999 Oct; 14(5):331-5. PubMed ID: 10850317
[No Abstract] [Full Text] [Related]
46. [Experiment with a new medullary radioprotector].
Bonnevie ; Cuche P; Rubet A; Papillon ; Chassard
Lyon Med; 1969 Mar; 221(10):533-7. PubMed ID: 5357284
[No Abstract] [Full Text] [Related]
47. Managing toxicities in pelvic malignancies.
Friedland J
J Support Oncol; 2004; 2(6 Suppl 3):19-23. PubMed ID: 15605921
[TBL] [Abstract][Full Text] [Related]
48. Prevention and management of radiation myelopathy.
Ang KK; Stephens LC
Oncology (Williston Park); 1994 Nov; 8(11):71-6; discussion 78, 81-2. PubMed ID: 7826840
[TBL] [Abstract][Full Text] [Related]
49. Radioprotective effects of amifostine on acute and chronic esophageal injury in rodents.
Vujaskovic Z; Thrasher BA; Jackson IL; Brizel MB; Brizel DM
Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):534-40. PubMed ID: 17869666
[TBL] [Abstract][Full Text] [Related]
50. Amifostine: is there evidence of tumor protection?
Koukourakis MI
Semin Oncol; 2003 Dec; 30(6 Suppl 18):18-30. PubMed ID: 14727237
[TBL] [Abstract][Full Text] [Related]
51. [Is there any experimental evidence for the application of radioprotective substances in radiotherapy?].
Huber R; Teichmann B
Arch Geschwulstforsch; 1971; 37(3):213-45. PubMed ID: 4941521
[No Abstract] [Full Text] [Related]
52. Indications for use of amifostine.
Santolaya-Perrin R; Castillo-Romera I; Requena-Caturla T
Am J Health Syst Pharm; 1998 Sep; 55(17):1827-8. PubMed ID: 9775347
[No Abstract] [Full Text] [Related]
53. Cytoprotective effects of amifostine in the treatment of childhood malignancies.
Cetingül N; Midyat L; Kantar M; Demirağ B; Aksoylar S; Kansoy S
Pediatr Blood Cancer; 2009 Jul; 52(7):829-33. PubMed ID: 19214974
[TBL] [Abstract][Full Text] [Related]
54. The role of radiation therapy in gastrointestinal bleeding.
Coia LR
J Support Oncol; 2005; 3(2):111-2. PubMed ID: 15796442
[No Abstract] [Full Text] [Related]
55. Does amifostine have a role in chemoradiation treatment?
Brizel DM; Overgaard J
Lancet Oncol; 2003 Jun; 4(6):378-81. PubMed ID: 12788413
[TBL] [Abstract][Full Text] [Related]
56. Some clinical results on selenium in radiation oncology: letter by O. Micke, R. Mücke, F. Bruns, K. Kisters, J. Büntzel on W. Dörr: Effects of selenium on radiation responses of tumor cells and tissue in: Strahlenther Onkol 2006;182:693-5 (No. 12) (DOI 10.1007/s00066-006-1595-8).
Micke O; Mücke R; Bruns F; Kisters K; Büntzel J
Strahlenther Onkol; 2007 Jun; 183(6):344-5. PubMed ID: 17520190
[No Abstract] [Full Text] [Related]
57. Specific protection of different normal tissues.
Rasey JS; Spence AM; Badger CC; Krohn KA; Vera DM; Livesey JC
Pharmacol Ther; 1988; 39(1-3):33-43. PubMed ID: 2849132
[No Abstract] [Full Text] [Related]
58. [Current status and perspectives of using radioprotectors in clinical practice].
Bondaruk OS; Moskalets' OI
Lik Sprava; 2003; (7):3-12. PubMed ID: 14723126
[TBL] [Abstract][Full Text] [Related]
59. Pharmacological intervention to prevent or ameliorate chronic radiation injuries.
Moulder JE
Semin Radiat Oncol; 2003 Jan; 13(1):73-84. PubMed ID: 12520466
[TBL] [Abstract][Full Text] [Related]
60. Radiobiology and clinical radiotherapy.
Travis EL; Peters LJ
Tex Med; 1984 Apr; 80(4):45-6. PubMed ID: 6328691
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
